oxaprozin

Generic: oxaprozin

Labeler: chartwell rx, llc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name oxaprozin
Generic Name oxaprozin
Labeler chartwell rx, llc.
Dosage Form TABLET
Routes
ORAL
Active Ingredients

oxaprozin 600 mg/1

Manufacturer
Chartwell RX, LLC.

Identifiers & Regulatory

Product NDC 62135-176
Product ID 62135-176_2526421a-bb2b-1e0b-e063-6394a90a42fc
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA075987
Listing Expiration 2026-12-31
Marketing Start 2004-09-02

Pharmacologic Class

Established (EPC)
nonsteroidal anti-inflammatory drug [epc]
Mechanism of Action
cyclooxygenase inhibitors [moa]
Chemical Structure
anti-inflammatory agents, non-steroidal [cs]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 62135176
Hyphenated Format 62135-176

Supplemental Identifiers

RxCUI
312132
UPC
0362135176600 0362135176181
UNII
MHJ80W9LRB
NUI
N0000000160 M0001335 N0000175722

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name oxaprozin (source: ndc)
Generic Name oxaprozin (source: ndc)
Application Number ANDA075987 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 600 mg/1
source: ndc
Packaging
  • 180 TABLET in 1 BOTTLE (62135-176-18)
  • 60 TABLET in 1 BOTTLE (62135-176-60)
source: ndc

Packages (2)

62135-176-18 180 TABLET in 1 BOTTLE (62135-176-18) 62135-176-60 60 TABLET in 1 BOTTLE (62135-176-60)

Ingredients (1)

oxaprozin (600 mg/1)

Linked Drug Pages (1)

OXAPROZIN ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "2526421a-bb2b-1e0b-e063-6394a90a42fc", "openfda": {"nui": ["N0000000160", "M0001335", "N0000175722"], "upc": ["0362135176600", "0362135176181"], "unii": ["MHJ80W9LRB"], "rxcui": ["312132"], "spl_set_id": ["db349233-9f09-471c-aeee-f91338d2ffe9"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "manufacturer_name": ["Chartwell RX, LLC."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "180 TABLET in 1 BOTTLE (62135-176-18)", "package_ndc": "62135-176-18", "marketing_start_date": "20220822"}, {"sample": false, "description": "60 TABLET in 1 BOTTLE (62135-176-60)", "package_ndc": "62135-176-60", "marketing_start_date": "20220822"}], "brand_name": "OXAPROZIN", "product_id": "62135-176_2526421a-bb2b-1e0b-e063-6394a90a42fc", "dosage_form": "TABLET", "pharm_class": ["Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Cyclooxygenase Inhibitors [MoA]", "Nonsteroidal Anti-inflammatory Drug [EPC]"], "product_ndc": "62135-176", "generic_name": "OXAPROZIN", "labeler_name": "Chartwell RX, LLC.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "OXAPROZIN", "active_ingredients": [{"name": "OXAPROZIN", "strength": "600 mg/1"}], "application_number": "ANDA075987", "marketing_category": "ANDA", "marketing_start_date": "20040902", "listing_expiration_date": "20261231"}